Fangdong Zou

1.7k total citations
61 papers, 1.3k citations indexed

About

Fangdong Zou is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Fangdong Zou has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Genetics and 13 papers in Cancer Research. Recurrent topics in Fangdong Zou's work include Genetic diversity and population structure (24 papers), Genomics and Phylogenetic Studies (10 papers) and Cancer-related molecular mechanisms research (8 papers). Fangdong Zou is often cited by papers focused on Genetic diversity and population structure (24 papers), Genomics and Phylogenetic Studies (10 papers) and Cancer-related molecular mechanisms research (8 papers). Fangdong Zou collaborates with scholars based in China, United States and Hong Kong. Fangdong Zou's co-authors include Lin Zhang, Jian Yu, Shuai Tan, Jingshan Tong, Bisong Yue, Hua Li, Austin Dulak, Xiaodong Zhang, Peng Wang and John S. Lazo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Fangdong Zou

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangdong Zou China 20 874 427 289 206 129 61 1.3k
Wenrui Duan United States 21 987 1.1× 212 0.5× 394 1.4× 183 0.9× 85 0.7× 53 1.4k
Jeong‐Hyeon Choi United States 23 1.2k 1.4× 378 0.9× 247 0.9× 202 1.0× 229 1.8× 40 1.8k
Ling Yao China 23 883 1.0× 525 1.2× 231 0.8× 200 1.0× 91 0.7× 104 1.4k
Jinpeng Liu United States 21 917 1.0× 346 0.8× 210 0.7× 185 0.9× 114 0.9× 77 1.6k
Mireia Jordà Spain 16 1.1k 1.2× 289 0.7× 430 1.5× 315 1.5× 92 0.7× 32 1.7k
Jihye Shin South Korea 21 1.1k 1.2× 344 0.8× 409 1.4× 134 0.7× 194 1.5× 68 1.8k
Tom Smith United Kingdom 12 1.5k 1.7× 352 0.8× 107 0.4× 137 0.7× 184 1.4× 30 2.0k
Tomoko Takahashi Japan 17 932 1.1× 216 0.5× 202 0.7× 226 1.1× 118 0.9× 36 1.5k
Oliver Coutelle Germany 19 934 1.1× 218 0.5× 249 0.9× 318 1.5× 167 1.3× 25 1.4k
Zhijun Wang China 20 1.1k 1.3× 720 1.7× 190 0.7× 168 0.8× 63 0.5× 93 1.7k

Countries citing papers authored by Fangdong Zou

Since Specialization
Citations

This map shows the geographic impact of Fangdong Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangdong Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangdong Zou more than expected).

Fields of papers citing papers by Fangdong Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangdong Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangdong Zou. The network helps show where Fangdong Zou may publish in the future.

Co-authorship network of co-authors of Fangdong Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Fangdong Zou. A scholar is included among the top collaborators of Fangdong Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangdong Zou. Fangdong Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Lijuan, et al.. (2025). Advances in combination therapy for the treatment of estrogen receptor positive breast cancer. Chinese Chemical Letters. 36(10). 111451–111451. 1 indexed citations
3.
Baba, Osamu, Fangdong Zou, Takahiro Horie, & Kisho Ono. (2024). A novel VCP modulator, KUS121, attenuates atherosclerosis progression by maintaining intracellular ATP and mitigating ER stress in endothelial cells. European Heart Journal. 45(Supplement_1). 1 indexed citations
4.
5.
Liang, Yutong, Lili Zhao, Yan Li, et al.. (2022). miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4. Cellular Signalling. 101. 110517–110517. 19 indexed citations
6.
Dong, Weifu, Yuan Luo, Guangjun Zhang, et al.. (2020). Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Gong, Shu, Dongsheng Xu, Jialin Zhu, Fangdong Zou, & Rui Peng. (2018). Efficacy of the MEK Inhibitor Cobimetinib and its Potential Application to Colorectal Cancer Cells. Cellular Physiology and Biochemistry. 47(2). 680–693. 30 indexed citations
8.
Tong, Jingshan, Shuai Tan, Zaneta Nikolovska‐Coleska, et al.. (2017). FBW7 -Dependent Mcl-1 Degradation Mediates the Anticancer Effect of Hsp90 Inhibitors. Molecular Cancer Therapeutics. 16(9). 1979–1988. 43 indexed citations
9.
Yang, Dong, Bin Sun, Xiaohong Zhang, et al.. (2017). Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3- H19 Cascade. Cancer Research. 77(18). 4773–4784. 37 indexed citations
10.
Tong, Jingshan, Peng Wang, Shuai Tan, et al.. (2017). Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells. Cancer Research. 77(9). 2512–2521. 104 indexed citations
11.
Gong, Shu, Dongsheng Xu, Fangdong Zou, & Rui Peng. (2017). (−)-Curine induces cell cycle arrest and cell death in hepatocellular carcinoma cells in a p53-independent way. Biomedicine & Pharmacotherapy. 89. 894–901. 10 indexed citations
12.
Zhang, Ziqi, et al.. (2016). CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines. DNA and Cell Biology. 35(7). 348–357. 37 indexed citations
13.
Tong, Jingshan, Shuai Tan, Fangdong Zou, Jian Yu, & Lin Zhang. (2016). FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation. Oncogene. 36(6). 787–796. 121 indexed citations
14.
Li, Si, Jingyan Fu, Caiyue Xu, et al.. (2015). Spatial Compartmentalization Specializes the Function of Aurora A and Aurora B. Journal of Biological Chemistry. 290(28). 17546–17558. 41 indexed citations
15.
Li, Si, Zhu Liang, Xu Liu, & Fangdong Zou. (2011). MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Molecular and Cellular Biochemistry. 360(1-2). 147–158. 71 indexed citations
16.
Wang, Peng, Fangdong Zou, Xiaodong Zhang, et al.. (2009). microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells. Cancer Research. 69(20). 8157–8165. 261 indexed citations
17.
Peng, Rui, et al.. (2009). Rediscovery of Protohynobius puxiongensis (Caudata: Hynobiidae) and its phylogenetic position based on complete mitochondrial genomes. Molecular Phylogenetics and Evolution. 56(1). 252–258. 22 indexed citations
18.
Zou, Fangdong, et al.. (2008). Genetic diversity of captive forest musk deer (Moschus berezovskii) inferred from the mitochondrial DNA control region. Animal Genetics. 40(1). 65–72. 24 indexed citations
19.
Zeng, Bo, et al.. (2008). Molecular phylogeography and genetic differentiation of blue sheep Pseudois nayaur szechuanensis and Pseudois schaeferi in China. Molecular Phylogenetics and Evolution. 48(2). 387–395. 20 indexed citations
20.
Zou, Fangdong, et al.. (1994). ECG data compression with wavelet and discrete cosine transforms.. PubMed. 30. 57–62. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenrui Duan Breakdown of academic impact, for papers by Jeong‐Hyeon Choi Breakdown of academic impact, for papers by Ling Yao Breakdown of academic impact, for papers by Jinpeng Liu Breakdown of academic impact, for papers by Mireia Jordà Breakdown of academic impact, for papers by Jihye Shin Breakdown of academic impact, for papers by Tom Smith Breakdown of academic impact, for papers by Tomoko Takahashi Breakdown of academic impact, for papers by Oliver Coutelle Breakdown of academic impact, for papers by Zhijun Wang
Rankless by CCL
2026